# Albemarle Corp: overview

ALB · NYSE · CIK 915913 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/alb.md) · [Financials](/companies/alb/financials.md) · [Filings](/companies/alb/filings.md) · [Insiders](/companies/alb/insiders.md)

Latest reported revenue: [$1.74bn](/filings/0000915913-26-000102.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0000915913-26-000102).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,355](/filings/0000915913-25-000162.md) | [1,232 d](/filings/0000915913-26-000018.md) | [1,077](/filings/0000915913-26-000072.md) | [1,330](/filings/0000915913-26-000102.md) | [1,308](/filings/0000915913-25-000162.md) | [1,428 d](/filings/0000915913-26-000018.md) | [1,429](/filings/0000915913-26-000072.md) | [1,743](/filings/0000915913-26-000102.md) |
| Gross margin | % | [(7.7%)](/filings/0000915913-25-000162.md) | [11.2% d](/filings/0000915913-26-000018.md) | [14.5%](/filings/0000915913-26-000072.md) | [14.8%](/filings/0000915913-26-000102.md) | [9.0%](/filings/0000915913-25-000162.md) | [13.9% d](/filings/0000915913-26-000018.md) | [35.1%](/filings/0000915913-26-000072.md) | [33.9%](/filings/0000915913-26-000102.md) |
| Operating margin | % | [(81.9%)](/filings/0000915913-25-000162.md) | [0.4% d](/filings/0000915913-26-000018.md) | [1.8%](/filings/0000915913-26-000072.md) | [3.6%](/filings/0000915913-26-000102.md) | [(16.6%)](/filings/0000915913-25-000162.md) | [(15.2%) d](/filings/0000915913-26-000018.md) | [16.3%](/filings/0000915913-26-000072.md) | [26.0%](/filings/0000915913-26-000102.md) |
| Net margin | % | [(78.9%)](/filings/0000915913-25-000162.md) | [6.1% d](/filings/0000915913-26-000018.md) | [3.8%](/filings/0000915913-26-000072.md) | [1.7%](/filings/0000915913-26-000102.md) | [(12.3%)](/filings/0000915913-25-000162.md) | [(29.0%) d](/filings/0000915913-26-000018.md) | [22.3%](/filings/0000915913-26-000072.md) | [27.5%](/filings/0000915913-26-000102.md) |
| Diluted EPS | $ per share | [(9.45)](/filings/0000915913-25-000162.md) | not reported | [0.00](/filings/0000915913-26-000072.md) | [(0.16)](/filings/0000915913-26-000102.md) | [(1.72)](/filings/0000915913-25-000162.md) | not reported | [2.34](/filings/0000915913-26-000072.md) | [3.52](/filings/0000915913-26-000102.md) |
| Free cash flow | $m | [(76.0) d](/filings/0000915913-25-000162.md) | [(347) d](/filings/0000915913-26-000018.md) | [365](/filings/0000915913-26-000072.md) | [(129) d](/filings/0000915913-26-000102.md) | [223 d](/filings/0000915913-25-000162.md) | [233 d](/filings/0000915913-26-000018.md) | [248](/filings/0000915913-26-000072.md) | [638 d](/filings/0000915913-26-000102.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,328](/filings/0000915913-24-000016.md) | [7,320](/filings/0000915913-25-000026.md) | [9,617](/filings/0000915913-26-000018.md) | [5,378](/filings/0000915913-26-000018.md) | [5,143](/filings/0000915913-26-000018.md) |
| Gross margin | % | [30.0%](/filings/0000915913-24-000016.md) | [42.0%](/filings/0000915913-25-000026.md) | [12.3%](/filings/0000915913-26-000018.md) | [1.2%](/filings/0000915913-26-000018.md) | [13.0%](/filings/0000915913-26-000018.md) |
| Operating margin | % | [24.0%](/filings/0000915913-24-000016.md) | [33.7%](/filings/0000915913-25-000026.md) | [2.6%](/filings/0000915913-26-000018.md) | [(33.0%)](/filings/0000915913-26-000018.md) | [(7.1%)](/filings/0000915913-26-000018.md) |
| Net margin | % | [3.7%](/filings/0000915913-24-000016.md) | [36.7%](/filings/0000915913-25-000026.md) | [16.4%](/filings/0000915913-26-000018.md) | [(21.9%)](/filings/0000915913-26-000018.md) | [(9.9%)](/filings/0000915913-26-000018.md) |
| Diluted EPS | $ per share | [1.06](/filings/0000915913-24-000016.md) | [22.84](/filings/0000915913-25-000026.md) | [13.36](/filings/0000915913-26-000018.md) | [(11.20)](/filings/0000915913-26-000018.md) | [(5.76)](/filings/0000915913-26-000018.md) |
| Free cash flow | $m | [(609)](/filings/0000915913-24-000016.md) | [651](/filings/0000915913-25-000133.md) | [(828)](/filings/0000915913-26-000018.md) | [(993)](/filings/0000915913-26-000018.md) | [692](/filings/0000915913-26-000018.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/alb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $1.34bn | 9,901,852 |  | Added +66,462 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.28bn | 9,501,587 |  | Added +766,750 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.04bn | 7,703,012 |  | Added +40,796 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $869.2m | 6,436,930 |  | Added +121,553 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $744.8m | 5,500,062 |  | Added +275,684 |
| [BARCLAYS PLC](/funds/312069.md) | 2026-06-30 | $445.1m | 3,296,551 |  | Added +2,060,833 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $421.9m | 3,129,997 |  | Reduced −304,050 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $391.0m | 2,895,892 |  | Added +648,001 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $374.2m | 2,771,000 | Put | Added +30,000 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $362.7m | 2,685,901 |  | Added +2,453,309 |

## Recent filings

[All 1,444 filings](/companies/alb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:15 ET | [8-K](/filings/0000915913-26-000124.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000915913-26-000124 |
| 2026-09-03 | 17:00 ET | [8-K](/filings/0001140361-26-035623.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-035623 |
| 2026-08-21 | 06:30 ET | [8-K](/filings/0000915913-26-000107.md) | 5.02 Departure or appointment of officers or directors | 0000915913-26-000107 |
| 2026-08-05 | 16:40 ET | [10-Q](/filings/0000915913-26-000102.md) | Quarterly report, period 2026-06-30 | 0000915913-26-000102 |
| 2026-08-05 | 16:22 ET | [8-K](/filings/0000915913-26-000101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915913-26-000101 |
| 2026-07-23 | 16:22 ET | [8-K](/filings/0000915913-26-000095.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000915913-26-000095 |
| 2026-06-05 | 16:15 ET | [8-K](/filings/0000915913-26-000087.md) | 5.02 Departure or appointment of officers or directors | 0000915913-26-000087 |
| 2026-05-08 | 16:40 ET | [8-K](/filings/0000915913-26-000075.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000915913-26-000075 |
| 2026-05-06 | 16:34 ET | [10-Q](/filings/0000915913-26-000072.md) | Quarterly report, period 2026-03-31 | 0000915913-26-000072 |
| 2026-05-06 | 16:19 ET | [8-K](/filings/0000915913-26-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915913-26-000070 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000915913-26-000018.md), filed Feb 11, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/d5e33b2c-5eba-48ca-909f-6e8fee2e2382)

## About the filer

- CIK: 915913
- Tickers: ALB, ALB-PA
- Exchange: NYSE
- SIC code: 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
- State of incorporation: VA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:23 ET. No prices; not investment advice.